Worth reading
60In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
1486
unitsWording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of share acquisition rights as stock options (Series 18 share acquisition rights)
発行・処分する株式数
1,000 common shares per share acquisition right; 1,486 rights in total (equivalent to a maximum of 1,486,000 shares)
Intended allottee
Name Executive directors of the Company / Number of Employees 2 / Number allocated 44 rights, Name Employees of the Company / Number of Employees 286 / Number allocated 1,348 rights, Name Executive directors of the wholly owned subsidiary / Number of Employees 12 / Number allocated 84 rights, Name Executive directors of other subsidiaries / Number of Employees 2 / Number allocated 10
Nil per stock acquisition right
Total issue value
No consideration
Amount of funds to be raised
Payment for share acquisition rights: ¥0; estimated net proceeds: ¥0
Terms of the stock acquisition rights
Exercise price
The higher of the average closing price on each trading day in the month preceding the month in which the allotment date falls and the closing price on the allotment date, multiplied by 1.05. Adjustment provisions apply in the event of a share split, share consolidation or similar event. The floor is Not disclosed.
Exercise period
Start Date 1 October 2028 / End date 30 September 2035
Number of Stock Acquisition Rights
Total number to be issued: 1,486 rights (planned); number of outstanding unexercised rights: Not disclosed
Reason for acquisition without consideration
If the share acquisition rights become unable to be transferred as a result of a corporate reorganization, the Company may acquire them without consideration on a date separately determined by the Company's Board of Directors.
Categories and Number of Persons Covered
Category Executive directors of the Company / Number of Employees 2 / Number of allocated shares Equivalent to 44,000 shares, Category Employees of the Company / Number of Employees 286 / Number of allocated shares Equivalent to 1,348,000 shares, Category Executive directors of the wholly owned subsidiary / Number of Employees 12 / Number of allocated shares Equivalent to 84,000 shares, Category Executive directors of other subsidiaries / Number of Employees 2 / Number of allocated shares Equivalent to 10,000 shares
Intended allottee's holding policy
The acquisition of the share acquisition rights through a transfer requires approval by resolution of the Company's Board of Directors.
Payment date
Not applicable (no monetary payment is required in exchange for the stock acquisition rights)
Basis for determining the amount to be paid
The exercise price will be the higher of the average closing price on each trading day in the month preceding the month in which the allotment date falls and the closing price on the allotment date, multiplied by 1.05. This represents a 5% premium.
Procedures under the Corporate Code of Conduct
The issuance of the share acquisition rights was approved at the Annual General Meeting of Shareholders held on 25 June 2026.
Most recent equity financing
Timing 20 May 2026 / Type Board of Directors resolution to submit the matter to the Annual General Meeting of Shareholders / Amount Not disclosed
Impact on Business Performance
The disclosure states that the purpose is to improve the performance of the Company Group as a whole and consolidated performance, but the specific financial impact is Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of share acquisition rights as stock options (Series 18 share acquisition rights) |
| Number of shares to be issued or disposed of | 1,000 common shares per share acquisition right; 1,486 rights in total (equivalent to a maximum of 1,486,000 shares) |
| Issue price and disposal price | Nil per stock acquisition right |
| Total issue value | No consideration |
| Amount of funds to be raised | Payment for share acquisition rights: ¥0; estimated net proceeds: ¥0 |
| Payment date | Not applicable (no monetary payment is required in exchange for the stock acquisition rights) |
| Intended allottee | Name Executive directors of the Company / Number of Employees 2 / Number allocated 44 rights, Name Employees of the Company / Number of Employees 286 / Number allocated 1,348 rights, Name Executive directors of the wholly owned subsidiary / Number of Employees 12 / Number allocated 84 rights, Name Executive directors of other subsidiaries / Number of Employees 2 / Number allocated 10 |
| Intended allottee's holding policy | The acquisition of the share acquisition rights through a transfer requires approval by resolution of the Company's Board of Directors. |
| Basis for determining the amount to be paid | The exercise price will be the higher of the average closing price on each trading day in the month preceding the month in which the allotment date falls and the closing price on the allotment date, multiplied by 1.05. This represents a 5% premium. |
| Exercise price | The higher of the average closing price on each trading day in the month preceding the month in which the allotment date falls and the closing price on the allotment date, multiplied by 1.05. Adjustment provisions apply in the event of a share split, share consolidation or similar event. The floor is Not disclosed. |
| Exercise period | Start Date 1 October 2028 / End date 30 September 2035 |
| Number of Stock Acquisition Rights | Total number to be issued: 1,486 rights (planned); number of outstanding unexercised rights: Not disclosed |
| Reason for acquisition without consideration | If the share acquisition rights become unable to be transferred as a result of a corporate reorganization, the Company may acquire them without consideration on a date separately determined by the Company's Board of Directors. |
| Categories and Number of Persons Covered | Category Executive directors of the Company / Number of Employees 2 / Number of allocated shares Equivalent to 44,000 shares, Category Employees of the Company / Number of Employees 286 / Number of allocated shares Equivalent to 1,348,000 shares, Category Executive directors of the wholly owned subsidiary / Number of Employees 12 / Number of allocated shares Equivalent to 84,000 shares, Category Executive directors of other subsidiaries / Number of Employees 2 / Number of allocated shares Equivalent to 10,000 shares |
| Procedures under the Corporate Code of Conduct | The issuance of the share acquisition rights was approved at the Annual General Meeting of Shareholders held on 25 June 2026. |
| Most recent equity financing | Timing 20 May 2026 / Type Board of Directors resolution to submit the matter to the Annual General Meeting of Shareholders / Amount Not disclosed |
| Impact on Business Performance | The disclosure states that the purpose is to improve the performance of the Company Group as a whole and consolidated performance, but the specific financial impact is Not disclosed |
Items this document does not state (11)
Estimated issuance expensesSpecific use of fundsDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To align the interests of shareholders with those of the Company's executive directors and employees by providing them with a common incentive to improve the performance of the Company Group as a whole, thereby improving consolidated performance.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.